Third-party lab testing: 18 independent Janoshik assays on file, covering 17 substances, median measured purity 99.5%, most recent test 2025-12-19.
| Substance | Measured purity | Test date |
|---|---|---|
| DSIP 5mg | 99.01% | 2025-12-19 |
| Tirzepatide 60mg | 99.95% | 2025-12-18 |
| Retatrutide 20mg | 99.54% | 2025-12-18 |
| HGH 191AA (somatropin) 151U | 97.83% | 2025-12-18 |
| Mots-c 10mg | 99.10% | 2025-10-21 |
| Retatrutide 30mg | 99.62% | 2025-10-21 |
| Retatrutide 20mg | 99.56% | 2025-10-21 |
| Retatrutide 5mg | 99.24% | 2025-10-21 |
| Retatrutide 15mg | 99.41% | 2025-10-21 |
| Retatrutide 50mg | 99.69% | 2025-10-21 |
| HGH 191AA(Somatropin 10IU | 97.50% | 2025-10-20 |
| Semax 10mg | 99.40% | 2025-07-04 |
| Tirzepatide 30mg | 99.97% | 2025-07-03 |
| Retatrutide 10mg | 99.86% | 2025-07-03 |
| Tesamorelin 10mg | 99.46% | 2025-05-28 |
| Cagrilintide 10mg | 99.76% | 2025-05-28 |
| GLOW 70mg | not reported | 2025-10-16 |
| Nad+ 500mg | not reported | 2025-07-02 |
16 of these 18 assays report a measured purity figure. The other 2 confirm the substance was submitted and tested but carry no purity number on the certificate, which is not the same as a failed result.